Lentiviral vectors: basic to translational

T Sakuma, MA Barry, Y Ikeda - Biochemical Journal, 2012 - portlandpress.com
More than two decades have passed since genetically modified HIV was used for gene
delivery. Through continuous improvements these early marker gene-carrying HIVs have …

Inhibition of Lassa and Marburg virus production by tetherin

T Sakuma, T Noda, S Urata, Y Kawaoka… - Journal of …, 2009 - Am Soc Microbiol
Recently, tetherin has been identified as an effective cellular factor that prevents the release
of human immunodeficiency virus type 1. Here, we show that the production of virus-like …

Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny

T Thatava, TJ Nelson, R Edukulla, T Sakuma… - Gene therapy, 2011 - nature.com
Nuclear reprogramming of somatic tissue enables derivation of induced pluripotent stem (iPS)
cells from an autologous, non-embryonic origin. The purpose of this study was to establish …

[HTML][HTML] Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells

…, K Squillace, JG De Lamo, YK Khan, T Sakuma… - Molecular Therapy, 2013 - cell.com
Nuclear reprogramming of adult somatic tissue enables embryo-independent generation of
autologous, patient-specific induced pluripotent stem (iPS) cells. Exploiting this emergent …

[HTML][HTML] Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency

…, AS Armstrong, T Thatava, T Sakuma… - Aging (Albany …, 2012 - ncbi.nlm.nih.gov
Nuclear reprogramming enables patient-specific derivation of induced pluripotent stem (iPS)
cells from adult tissue. Yet, iPS generation from patients with type 2 diabetes (T2D) has not …

Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy

JM Tonne, T Sakuma, MC Deeds… - Disease models & …, 2013 - journals.biologists.com
Streptozotocin (STZ), a glucosamine-nitrosourea compound, has potent genotoxic effects
on pancreatic β-cells and is frequently used to induce diabetes in experimental animals. …

β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection

MM El Khatib, T Sakuma, JM Tonne, MS Mohamed… - Gene therapy, 2015 - nature.com
Protection of β cells from autoimmune destruction potentially cures type 1 diabetes mellitus (T1D).
During antigen presentation, interactions between cytotoxic T-lymphocyte antigen-4 (…

[HTML][HTML] Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation

…, JG De Lamo, R Edukulla, YK Khan, T Sakuma… - Stem cell research & …, 2011 - Springer
Introduction End-stage renal disease (ESRD) is a major public health problem. Although
kidney transplantation is a viable therapeutic option, this therapy is associated with significant …

Secretion of glycosylated pro–B-type natriuretic peptide from normal cardiomyocytes

…, A Cataliotti, S Ohmine, T Thatava, T Sakuma… - Clinical …, 2011 - academic.oup.com
BACKGROUND B-type natriuretic peptide (BNP), a key cardiac hormone in cardiorenal
homeostasis, is produced as a 108 amino acid prohormone, proBNP1-108, which is converted to …

[HTML][HTML] An siRNA screen identifies the U2 snRNP spliceosome as a host restriction factor for recombinant adeno-associated viruses

CA Schreiber, T Sakuma, Y Izumiya, SJ Holditch… - PLoS …, 2015 - journals.plos.org
Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host
cell machinery during co-infection by adenoviruses and other helper viruses. In the absence …